FDA Inspection 1176114 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1276530

The FDA completed an inspection of American Red Cross Blood Services on July 7, 2022 in Bangor, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 7, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Bangor, ME (United States)